Advertisement
UK markets open in 3 hours 8 minutes
  • NIKKEI 225

    37,772.13
    -687.95 (-1.79%)
     
  • HANG SENG

    17,267.78
    +66.51 (+0.39%)
     
  • CRUDE OIL

    82.83
    +0.02 (+0.02%)
     
  • GOLD FUTURES

    2,322.20
    -16.20 (-0.69%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,648.66
    -1,811.89 (-3.39%)
     
  • CMC Crypto 200

    1,390.94
    -33.16 (-2.33%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Novartis’s 1Q18 Estimates: Expectations for Sandoz

Novartis’s 1Q18 Estimates: Expectations for Sandoz

Sandoz, the generics arm of Novartis (NVS), includes pharmaceuticals and biotechnological active substances in its portfolio. Sandoz is expected to report growth in operating revenue in 1Q18.